Wen, S., Zeng, J., Zhong, L., Ye, J., & Lai, X. (2022). The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma: Nivolumab and lenvatinib in the treatment of HCC. Cellular and Molecular Biology, 68(11), 53–57. https://doi.org/10.14715/cmb/2022.68.11.10